Thioredoxin as a modulator of transcription factor binding

Research output: Contribution to journalArticle

Abstract

Our laboratory is interested in the role of thioredoxin in regulathg cellular redox status in airway epithelium. Specifically, I have been examining how thioredoxin modulates binding of transcription factors. My previous data illustrated that thioredoxin enhances binding of NF-κB, and that this increased binding was un que to thioredoxin. Other thiols such as N-acetyl-cysteine and glutathione were unable to increase binding of NF-κB. I have extended this work for the transcription factor AP-1 and have obtained similar results. Using primary monkey tracheobronchial epithelial cells and an immortalized human tracheobronchial cell line, HBE1, we observed that TNF-α, PMA, and retinoic acid increase the binding activity of AP-1 as measured by gel mobility shift assays (GMSA). This increased binding was further enhanced by the addition of thioredoxin to nuclear extracts. Antibodies to the c-Jun component of AP-1 were used to confirm AP-1 specificity. Transactivation assays were performed in order to correlate the GMSA results with functional promoter activity. Two constructs were used utilizing a 161 base pair spr-1 promoter, which contains two AP-1 consensus sequences, attached to a chloramphenicol acetyltransferase reporter gene. The -162-spr1-CAT3 construct contained two funtional AP-1 sites, whereas the -162-spv1-double mutant-CAT3 construct had mutations at both AP-1 sites. Increased CAT activity, as measured by ELISA, was seen under stimulated conditions with the -162-spr1-CAT3 construct. This increased activity was abolished when the mutant construct was used. These results, together with our previous data, suggest that thioredoxin plays a unique role by increasing transcription factor binding in airway epithelial cells.

Original languageEnglish (US)
JournalJournal of Investigative Medicine
Volume47
Issue number2
StatePublished - Feb 1999

Fingerprint

Thioredoxins
Transcription Factor AP-1
Modulators
Transcription Factors
Assays
Electrophoretic Mobility Shift Assay
Acetylcysteine
Gels
Epithelial Cells
Chloramphenicol O-Acetyltransferase
Consensus Sequence
Tretinoin
Reporter Genes
Sulfhydryl Compounds
Base Pairing
Transcriptional Activation
Oxidation-Reduction
Haplorhini
Cysteine
Epithelium

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Thioredoxin as a modulator of transcription factor binding. / Harper, Richart W; Wu, Reen.

In: Journal of Investigative Medicine, Vol. 47, No. 2, 02.1999.

Research output: Contribution to journalArticle

@article{76f3fb6aeb70445d9bc40bb94b50f70e,
title = "Thioredoxin as a modulator of transcription factor binding",
abstract = "Our laboratory is interested in the role of thioredoxin in regulathg cellular redox status in airway epithelium. Specifically, I have been examining how thioredoxin modulates binding of transcription factors. My previous data illustrated that thioredoxin enhances binding of NF-κB, and that this increased binding was un que to thioredoxin. Other thiols such as N-acetyl-cysteine and glutathione were unable to increase binding of NF-κB. I have extended this work for the transcription factor AP-1 and have obtained similar results. Using primary monkey tracheobronchial epithelial cells and an immortalized human tracheobronchial cell line, HBE1, we observed that TNF-α, PMA, and retinoic acid increase the binding activity of AP-1 as measured by gel mobility shift assays (GMSA). This increased binding was further enhanced by the addition of thioredoxin to nuclear extracts. Antibodies to the c-Jun component of AP-1 were used to confirm AP-1 specificity. Transactivation assays were performed in order to correlate the GMSA results with functional promoter activity. Two constructs were used utilizing a 161 base pair spr-1 promoter, which contains two AP-1 consensus sequences, attached to a chloramphenicol acetyltransferase reporter gene. The -162-spr1-CAT3 construct contained two funtional AP-1 sites, whereas the -162-spv1-double mutant-CAT3 construct had mutations at both AP-1 sites. Increased CAT activity, as measured by ELISA, was seen under stimulated conditions with the -162-spr1-CAT3 construct. This increased activity was abolished when the mutant construct was used. These results, together with our previous data, suggest that thioredoxin plays a unique role by increasing transcription factor binding in airway epithelial cells.",
author = "Harper, {Richart W} and Reen Wu",
year = "1999",
month = "2",
language = "English (US)",
volume = "47",
journal = "Journal of Investigative Medicine",
issn = "1081-5589",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Thioredoxin as a modulator of transcription factor binding

AU - Harper, Richart W

AU - Wu, Reen

PY - 1999/2

Y1 - 1999/2

N2 - Our laboratory is interested in the role of thioredoxin in regulathg cellular redox status in airway epithelium. Specifically, I have been examining how thioredoxin modulates binding of transcription factors. My previous data illustrated that thioredoxin enhances binding of NF-κB, and that this increased binding was un que to thioredoxin. Other thiols such as N-acetyl-cysteine and glutathione were unable to increase binding of NF-κB. I have extended this work for the transcription factor AP-1 and have obtained similar results. Using primary monkey tracheobronchial epithelial cells and an immortalized human tracheobronchial cell line, HBE1, we observed that TNF-α, PMA, and retinoic acid increase the binding activity of AP-1 as measured by gel mobility shift assays (GMSA). This increased binding was further enhanced by the addition of thioredoxin to nuclear extracts. Antibodies to the c-Jun component of AP-1 were used to confirm AP-1 specificity. Transactivation assays were performed in order to correlate the GMSA results with functional promoter activity. Two constructs were used utilizing a 161 base pair spr-1 promoter, which contains two AP-1 consensus sequences, attached to a chloramphenicol acetyltransferase reporter gene. The -162-spr1-CAT3 construct contained two funtional AP-1 sites, whereas the -162-spv1-double mutant-CAT3 construct had mutations at both AP-1 sites. Increased CAT activity, as measured by ELISA, was seen under stimulated conditions with the -162-spr1-CAT3 construct. This increased activity was abolished when the mutant construct was used. These results, together with our previous data, suggest that thioredoxin plays a unique role by increasing transcription factor binding in airway epithelial cells.

AB - Our laboratory is interested in the role of thioredoxin in regulathg cellular redox status in airway epithelium. Specifically, I have been examining how thioredoxin modulates binding of transcription factors. My previous data illustrated that thioredoxin enhances binding of NF-κB, and that this increased binding was un que to thioredoxin. Other thiols such as N-acetyl-cysteine and glutathione were unable to increase binding of NF-κB. I have extended this work for the transcription factor AP-1 and have obtained similar results. Using primary monkey tracheobronchial epithelial cells and an immortalized human tracheobronchial cell line, HBE1, we observed that TNF-α, PMA, and retinoic acid increase the binding activity of AP-1 as measured by gel mobility shift assays (GMSA). This increased binding was further enhanced by the addition of thioredoxin to nuclear extracts. Antibodies to the c-Jun component of AP-1 were used to confirm AP-1 specificity. Transactivation assays were performed in order to correlate the GMSA results with functional promoter activity. Two constructs were used utilizing a 161 base pair spr-1 promoter, which contains two AP-1 consensus sequences, attached to a chloramphenicol acetyltransferase reporter gene. The -162-spr1-CAT3 construct contained two funtional AP-1 sites, whereas the -162-spv1-double mutant-CAT3 construct had mutations at both AP-1 sites. Increased CAT activity, as measured by ELISA, was seen under stimulated conditions with the -162-spr1-CAT3 construct. This increased activity was abolished when the mutant construct was used. These results, together with our previous data, suggest that thioredoxin plays a unique role by increasing transcription factor binding in airway epithelial cells.

UR - http://www.scopus.com/inward/record.url?scp=33750108693&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750108693&partnerID=8YFLogxK

M3 - Article

VL - 47

JO - Journal of Investigative Medicine

JF - Journal of Investigative Medicine

SN - 1081-5589

IS - 2

ER -